sulfasalazine has been researched along with A-V Dissociation in 2 studies
Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Butt, SU | 1 |
| McNeil, J | 1 |
| Ulusoy, V | 1 |
| Ateş, A | 1 |
| Ciçekcioğlu, H | 1 |
| Avcioğlu, Y | 1 |
| Karaaslan, Y | 1 |
2 other studies available for sulfasalazine and A-V Dissociation
| Article | Year |
|---|---|
Complete heart block in a Caucasian woman with Behçet's disease: a case report.
Topics: Anti-Inflammatory Agents; Behcet Syndrome; Electrocardiography; Female; Heart Block; Humans; Middle | 2016 |
Third-degree heart block developing in a female patient with HLA-B27 positive ankylosing spondylitis.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Electrocardiography; Female; Follow-Up Studies; Hear | 2006 |